SCHEDULE 13G HOLDINGS REPORT

Company

Jasper Therapeutics, Inc.

Filed

December 2, 2019

Accession Number

0001172661-19-002402

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →